What is the recommended dose of amitriptyline in children?

Amitriptyline Dosing in Children

Amitriptyline is not recommended for children under 12 years of age due to lack of safety and efficacy data in this population 1. For adolescents 12 years and older, the recommended starting dose is 10 mg three times daily with 20 mg at bedtime, which may be satisfactory for those who do not tolerate higher dosages 1.

FDA-Approved Dosing for Adolescents (≥12 years)

The FDA drug label provides clear guidance for adolescent patients 1:

• Starting dose: 10 mg three times daily plus 20 mg at bedtime (total 50 mg/day)
• Alternative initiation: 50-100 mg at bedtime, increased by 25-50 mg as needed up to 150 mg/day
• Maintenance: Typically 50-100 mg per day, with some patients requiring only 40 mg/day
• Maximum: Generally not to exceed 150 mg/day in outpatient settings

The lower dosing recommendation for adolescents reflects their reduced tolerance compared to adults 1.

Pediatric Use Under 12 Years

The FDA explicitly states that amitriptyline is not recommended for patients under 12 years of age 1. This restriction exists because:

• Lack of clinical experience in this age group
• Insufficient safety data
• Unknown risk-benefit profile in younger children

Clinical Context from Research

While the FDA label restricts use to adolescents ≥12 years, some clinical studies have explored off-label use in younger children:

For migraine prophylaxis: One study used 1 mg/kg/day in children as young as 8 years 2, though this trial found no superiority over placebo and was associated with adverse events including fatigue (30%) and mood alterations 2.

For functional abdominal pain: Low doses of 10-25 mg have been studied in children 8-17 years 3, with EKG monitoring showing increased heart rate and QTc interval, though no clinically significant arrhythmias developed 3.

Critical Safety Considerations

Cardiac Monitoring

• Baseline EKG required before initiating therapy to exclude long QT syndrome 1
• Particularly important given family history of sudden cardiac death, palpitations, or syncope 4
• Amitriptyline can cause QT prolongation, arrhythmias, and is potentially cardiotoxic in overdose 1

Psychiatric Risks

• Black box warning: Increased risk of suicidal thinking and behavior in children and adolescents 1
• Screen for bipolar disorder before initiating treatment 1
• Monitor for mood changes, which can occur early in treatment 4

Overdose Risk

• Potentially fatal in overdose due to cardiotoxicity 4
• Must be kept securely locked away from younger siblings 4
• This is a major safety concern that limits use in pediatric populations

Practical Dosing Algorithm for Adolescents ≥12 Years

If prescribing is deemed necessary despite limited evidence:

1. Initiation: Start with 10 mg at bedtime
2. Titration: Increase by 10-25 mg every 3-5 days as tolerated
3. Target dose: 50-75 mg at bedtime for most adolescents
4. Maximum: 150 mg/day (rarely 200 mg in hospitalized patients under close supervision)
5. Timing: Preferably given at bedtime due to sedative effects

Monitoring Requirements

• Baseline EKG and repeat if dose exceeds 100 mg/day
• Monitor for anticholinergic effects: dry mouth, constipation, urinary retention, blurred vision
• Assess for mood changes, particularly in first 4-8 weeks
• Plasma levels may be useful if toxicity suspected or lack of response (therapeutic range for amitriptyline plus nortriptyline: 80-200 ng/mL) 5

Common Pitfalls to Avoid

1. Do not prescribe to children under 12 years - this is off-label with insufficient safety data
2. Do not skip cardiac screening - baseline EKG is essential given arrhythmia risk
3. Do not ignore psychiatric history - screen for bipolar disorder and suicidality
4. Do not use adult doses - adolescents require lower doses (10-150 mg vs adult 75-300 mg)
5. Do not overlook drug storage - emphasize secure storage due to fatal overdose potential

Alternative Considerations

Given the limited evidence for efficacy and significant safety concerns in pediatric populations, consider alternative approaches first 6:

• For cyclic vomiting syndrome: Goal dose of 1-1.5 mg/kg at bedtime (75-150 mg) with slow titration 6
• For neuropathic pain: Gabapentin or pregabalin may be safer alternatives 7, 8
• For migraine: The CHAMP trial found no benefit over placebo in children 8-17 years 2

The evidence does not support routine use of amitriptyline in children under 12 years, and use in adolescents should be reserved for specific indications after careful risk-benefit assessment and with appropriate monitoring.